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Control strategies are especially challenging for microbial diseases caused by pathogens
that persist in wildlife reservoirs and use arthropod vectors to cycle amongst those
species. One of the most relevant illnesses that pose a direct human health risk is Lyme
disease; in the US, the Centers for Disease Control and Prevention recently revised the
probable number of cases by 10-fold, to 300,000 cases per year. Caused by Borrelia
burgdorferi, Lyme disease can affect the nervous system, joints and heart. No human
vaccine is approved by the Food and Drug Administration. In addition to novel human
vaccines, new strategies for prevention of Lyme disease consist of pest management
interventions, vector-targeted vaccines and reservoir-targeted vaccines. However, even
human vaccines can not prevent Lyme disease expansion into other geographical areas.
The other strategies aim at reducing tick density and at disrupting the transmission of
B. burgdorferi by targeting one or more key elements that maintain the enzootic cycle:
the reservoir host and/or the tick vector. Here, I provide a brief overview of the application
of an OspA-based wildlife reservoir targeted vaccine aimed at reducing transmission of
B. burgdorferi and present it as a strategy for reducing Lyme disease risk to humans.
Keywords: Borrelia burgdorferi , Lyme disease, enzootic cycle, oral vaccination, transmission cycles, wildlife
reservoir
Given the unabated increase in Lyme disease in the US, public
health officials are searching for effective and creative solutions
to quell the epidemic. The immunization of animals as a means
of preventing disease in humans and in domesticated animals of
agricultural economic interest was comprehensively reviewed by
Monath (2013). The use of reservoir targeted vaccines to control
disease is an attractive but under-explored concept. This approach
benefits primarily zoonotic diseases in which wild animals play
a major role in transmitting the pathogen to humans such as
plague, rabies and Lyme disease but it can be easily applied to
other vector-borne and directly transmitted diseases. Here my
goal is to provide an update on progress toward a wildlife targeted
vaccine as a means to reduce risk of exposure to Lyme disease,
while discussing its strengths, limitations and a framework for its
application.
BORRELIA BURGDORFERI AND LYME DISEASE
Lyme disease was clinically characterized after an epidemic of
asymmetrical arthritis affecting multiple joints was observed in
children in Lyme, Connecticut, US in 1977 (Steere et al., 1977).
The disease has steadily increased in incidence (Kugeler et al.,
2008) and has expanded its geographic range (Kugeler et al., 2008;
Diuk-Wasser et al., 2012). Caused by a spirochete, B. burgdor-
feri sensu stricto (s.s.) (Benach et al., 1983; Steere et al., 1983),
Lyme disease accounts for>90% of all vector-borne diseases with
nearly 30,000 confirmed cases reported each year to the Center
for Disease Control and Prevention (CDC). Recently the CDC
revised the number of probable infections upward 10-fold (to
300,000) to account for wide underreporting (http://www.cdc.
gov/lyme/) (Young, 1998).
Lyme disease spirochetes are transmitted to reservoir hosts by
hard-bodied ticks (Burgdorfer, 1989). Because the B. burgdorferi
genome does not encode any known toxins or the machinery
that would be required to secrete them (Fraser et al., 1997),
tissue damage and disease are mediated by the inflammatory
response that follows infection in the mammalian host (Weis and
Bockenstedt, 2010). Erythema migrans is the most common clin-
ical manifestation of B. burgdorferi infection (60–80%) (Stanek
et al., 2012) and develops after an incubation period of 2–32 days
(Wormser et al., 2006). Most cases of erythema migrans occur
between June and August (Kugeler et al., 2008). Low level spiro-
chetemia occurs in ∼50% of untreated patients presenting with
signs of early Lyme disease (Wormser et al., 2005). Occasionally,
Lyme disease affects the peripheral or central nervous system,
joints or heart months after infection (Steere, 1989).
THE ENZOOTIC CYCLE AND TRANSMISSION
Transmission of B. burgdorferi occurs in rural areas used for
forestry and recreational activities and in peridomestic suburban
areas (Piesman and Gern, 2004; Stanek et al., 2012). Development
and survival of the ticks depends on the level of humidity pro-
vided by a layer of decaying vegetation in the understory of decid-
uous or mixed woodlands which provide support and shelter to
a range of vertebrate reservoir hosts that sustain transmission of
the bacterium (Stanek et al., 2012) in states endemic for Lyme
disease.
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Borrelia burgdorferi is transmitted by at least four species of
tick within the Ixodes ricinus-persulcatus complex: I. scapularis
and I. pacificus in eastern and western North America, respec-
tively; I. ricinus in Europe, and I. persulcatus in Asia (Burgdorfer,
1989). These ticks go through a four-stage life cycle (egg, larvae,
nymph, and adult) feeding only once per active stage. Unfed ticks
attach to the skin of a host as the animal passes through vegeta-
tion. After feeding for 3–7 days the ticks drop off their host and
take shelter under leaf litter where they need a minimum rela-
tive humidity of 80% to survive (Piesman and Gern, 2004). They
take several months to molt into the next stage of development
(Stanek et al., 2012). Larvae are uninfected as they hatch—there
is no transovarial transmission (Patrican, 1997)—and B. burgdor-
feri is acquired upon feeding on an infected reservoir host. After
molting to the nymphal stage, the tick transmits the pathogen
to a susceptible animal or human providing its next blood meal.
Transmission of Lyme borreliae occurs through injection of tick
saliva during feeding (Ribeiro et al., 1987). A feeding period of at
least 36 h is needed for transmission of B. burgdorferi by I. scapu-
laris or I. pacificus ticks (Peavey and Lane, 1995; des Vignes et al.,
2001) and infection becomes increasingly likely after the tick has
been attached for 48 h (Piesman et al., 1987).
The life cycle of all four species of ticks have distinct seasonal-
ity. I. scapularis nymphs are active in early summer and adults
become active in the fall, remain so until winter and become
active again in the spring; furthermore, after the fall and winter,
nymphal ticks from the following tick cohort undergo questing
in the spring (Piesman and Gern, 2004). In the case of I. rici-
nus and I. persulcatus, nymphs and adults become active in early
spring and continue to seek hosts until mid-summer; both stages
can be active until later in the year in sheltered humid environ-
ments. With I. ricinus a second peak of activity can occur in the
fall. Patterns of activity of I. pacificus, prevalent in the western US,
seem more like those of I. ricinus than I. scapularis (Piesman and
Gern, 2004). In all species, peak activity usually occurs slightly
later in larvae than in nymphs, especially for I. scapularis in
the eastern US. The 3 month difference between one cohort of
I. scapularis nymphal activity and the following cohort of lar-
val activity allows plenty of time for transmission from infected
reservoir hosts to larvae and could explain the high transmis-
sion rate in the eastern US (Eisen et al., 2002). Most transmission
to humans occurs from May to September, coinciding with the
activity of nymphs and with the increasing recreational use of tick
habitats by the public (Kugeler et al., 2008; Stanek et al., 2012).
Field studies in North America and Eurasia have identified a
variety of small-mammal and avian reservoirs in enzootic trans-
mission cycles (Table 1). The white-footed mouse, Peromyscus
leucopus, is considered to be the main reservoir in the northeast-
ern US (Anderson, 1989). In most tick habitats, deer are essential
for the maintenance of the tick population (Anderson, 1989)
because they are one of the few wild hosts that can feed suffi-
cient numbers of adult ticks and keep the cycle ongoing, but they
are not competent reservoirs for spirochetes (Matuschka et al.,
1993). Cattle are non-competent hosts and sheep also appear
to be non-competent reservoirs (Matuschka et al., 1993; Ogden
et al., 1997). Different pathogenic genospecies of B burgdorferi
sensu lato favor some vertebrates as reservoir hosts, though this
Table 1 | The reservoir competence of vertebrate species.
Species Geographical References
area
Competent Mouse US/Europe De Boer et al., 1993;
LoGiudice et al.,
2003
Voles Europe De Boer et al., 1993
Chipmunk US LoGiudice et al.,
2003
Shrew US LoGiudice et al.,
2003; Dykhuizen
et al., 2008
Squirrel US/Europe LoGiudice et al.,
2003; Mannelli et al.,
2012
Ground birds US/Europe LoGiudice et al.,
2003; Mannelli et al.,
2012




Deer US/Europe Gray et al., 1992;
LoGiudice et al.,
2003
Cattle Europe Mannelli et al., 2012
Opossum US LoGiudice et al.,
2003
Raccoon US LoGiudice et al.,
2003
Lizards US/Europe Casher et al., 2002;




Catbirds US Mather et al., 1989;
Ginsberg et al., 2005
Sheep Europe Gray et al., 1995;
Ogden et al., 1997
Not
confirmed
Hare Europe Jaenson and
Talleklint, 1996
Hedgehog Europe Gern et al., 1997
Badgers Europe Mannelli et al., 2012
Red foxes Europe Mannelli et al., 2012
Reservoir competence is the ability of a host to become infected, remain sys-
temically infected and then transmit the pathogen to a feeding vector (Gray et al.,
2002); from a population level, it is the probability that an infected host trans-
mits B. burgdorferi to feeding ticks (Brunner et al., 2008). Reservoir competence
is the product of (1) the probability the host is infected (infection prevalence),
and (2) the probability an infected host will transmit the infection to a feeding
vector (infectivity). Prevalence varies in space and time, whereas infectivity is a
property of the host species and it depends on the strain of B. burgdorferi.
host specificity is not absolute. One factor thought to be rele-
vant to reservoir competence is the resistance of the particular
genospecies of Lyme borreliae to complement-mediated killing by
the animal host (Bykowski et al., 2008). Populations of deer in a
tick habitat can be regarded as a good indication of Lyme disease
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risk because an array of other hosts, including reservoir compe-
tent animals, are likely to be present. If most animals in a habitat
are those which do not act as reservoirs for Lyme borreliae, such
as deer or cattle, Lyme disease risk may decrease because ticks will
feed mostly on these animals and therefore will reinforce a pos-
itive feedback loop by not becoming infected (LoGiudice et al.,
2003). However, this is a highly debated issue. The presence of
diversionary hosts may reduce the proportion of ticks infected,
but may actually increase the overall abundance of infected ticks
because they augment the entire tick population, allowing more
larvae to feed on reservoir competent hosts vs. a smaller popu-
lation (Ogden and Tsao, 2009; Mannelli et al., 2012; Randolph
and Dobson, 2012; Wood and Lafferty, 2013). The specific effect
probably varies with the hosts involved and with the degree non-
competent hosts “out-compete” the reservoir hosts for juvenile
ticks (Ogden and Tsao, 2009).
THE HUMAN OspA VACCINE AND OTHER METHODS OF
PREVENTION
There are multiple strategies for prevention of Lyme disease.
Direct vaccination of humans could have been the gold stan-
dard for prevention of Lyme disease, as vaccination in general
is the gold standard for prevention of a multitude of infec-
tious diseases. A vaccine based on OspA protected mice against
B. burgdorferi infection after tick challenge (Fikrig et al., 1992a,b;
de Silva et al., 1996); this work led to successful clinical trials that
culminated in the approval of the human vaccine by the FDA
in 1998. Individuals vaccinated subcutaneously showed approx-
imately ∼76% protection against B. burgdorferi infection after
receiving three vaccine doses (Steere et al., 1998). Despite ade-
quate efficacy results, the human vaccine was removed from the
market. Other vaccines based on assorted combinations of four to
eight OspC types appear to be promising candidates as preventive
measures against Lyme disease (Seinost et al., 1999; Earnhart and
Marconi, 2007; Earnhart et al., 2007).
However, disease expansion into new geographical areas
(Burgdorfer, 1989; Ogden et al., 2005; Kugeler et al., 2008;
Mannelli et al., 2012) can not be controlled by promoting only
direct human vaccination programs. Given that humans are only
incidental hosts of B. burgdorferi, even mandatory human vac-
cination will not reduce B. burgdorferi from its enzootic cycle;
B. burgdorferiwill simply cycle through its reservoir hosts and vec-
tors until optimal environmental conditions and breaches in vac-
cine effectiveness allow for its recurrence. Integrated approaches
that build upon effective methods to contain B. burgdorferi infec-
tion within its enzootic cycle as well as direct vaccination of
humans would lead to a synergistic effect in public health more
likely to yield sustainable positive outcomes (Monath, 2013).
CONTROL OF TICK DENSITY
Human risk of Lyme disease from an environmental perspective
is measured in terms of density of infected nymphs (Diuk-
Wasser et al., 2012). Other methods of tick control have been
explored to reduce the risk of Lyme disease ranging from avoiding
tick infested environs, covering exposed skin, using tick repel-
lents, bathing within 2 h of tick exposure, to daily inspections
of the entire skin surface to remove attached ticks (Connally
et al., 2009), to chemoprophylaxis after removal of attached ticks
(Wormser et al., 2007; Warshafsky et al., 2010). Management of
wood chips where lawns are adjacent to forests, application of aca-
ricides, and the construction of fences to keep out deer are also
effective, as these measures disturb the habitat where the density
of host seeking ticks is high (Piesman, 2006). Acaricide self-
treatment of white-tailed deer resulted in reduction of tick density
(Hoen et al., 2009; Stafford et al., 2009) and a rodent-targeted
acaricide (fipronil) delivered to white-footed mice (P. leucopus)
in modified commercial bait boxes was also effective in reduc-
ing nymphal and larval tick infestations as it reduced tick density
(Dolan et al., 2004). A decrease in tick density is expected to
reduce human exposure to Lyme disease as it would reduce
density of infected ticks.
RESERVOIR TARGETED VACCINES
Vaccines targeted to the host reservoir have been developed as
strategies to reduce transmission of pathogens (Piesman, 2006).
Baits and baiting systems have proven effective for delivery of
rabies and plague vaccines (Pastoret et al., 1988; Creekmore et al.,
2002; Knobel et al., 2002). An example of a successful application
is the oral baited vaccine Raboral™ currently used by local gov-
ernments in the United States to create barriers between infected
wildlife and highly populated areas to prevent transmission of
rabies (Blanton et al., 2012).
Ixodes scapularis and I. pacificus ticks and its competent reser-
voirs are distributed across the US in many areas where Lyme
disease is not endemic as appears to be the case in California
(Eisen et al., 2009) and in the Southern states of the US (Oliver
et al., 2003). In the presence of both competent reservoir and
tick vector, one reason for the lack of Lyme disease in these
areas could be that environmental weather conditions dramati-
cally affects the ecology of the habitat that sustains the enzootic
cycle of B. burgdorferi and enable pathogen transmission (Eisen
et al., 2002). Another way to achieve the same goal would be
to remove B. burgdorferi from the enzootic cycle through the
application of reservoir targeted vaccines.
Although eradicating the main reservoir host(s), deer and the
vector are measures generally accepted as effective in disrupting
transmission of B. burgdorferi, the fact that the competent reser-
voir and vector co-exist in areas where B. burdgorferi does not
appear to be transmitted to humans argues against the neces-
sity of implementing drastic measures to eliminate any. It further
argues in favor of a solution that is less disruptive of an ecosystem
that sustain life and lifestyles. Thus, preventing the vector from
acquiring or transmitting an organism may be an effective strat-
egy for preventing Lyme disease in humans (Clark and Hu, 2008).
Although elimination of Lyme borreliae from nature is unreal-
istic, diminishing their threat to humans is an achievable goal
(Radolf et al., 2012).
The reservoir host that is most competent for transmission of
B. burgdorferi in the US is the white-footed mouse (Peromyscus
leucopus) (Anderson et al., 1987; Anderson, 1989). However,
chipmunks, squirrels, shrews, and other small vertebrates are
increasingly recognized as important hosts (Brisson et al., 2008).
Further, birds may also play a role in spreading B. burgdor-
feri (Burgdorfer, 1989; Comstedt et al., 2006; Ogden et al.,
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2010). The principle behind development of reservoir targeted
vaccines (RTV) is to reduce B. burgdorferi from the reservoir
host(s) and from the ticks that feed on them. In other words,
the ultimate objective of RTV vaccination is to turn compe-
tent reservoir hosts into incompetent hosts while at the same
time depleting B. burgdorferi from the vector without eradicat-
ing either (the vertebrate host or the tick) from the ecosystem
(Figure 1).
OspA was previously used to vaccinate mice orally (Fikrig
et al., 1991; Luke et al., 1997). Two groups have been develop-
ing baited OspA-based oral delivery systems to vaccinate reservoir
hosts against Lyme disease. One delivery system is based on
Vaccinia virus (VV) (Scheckelhoff et al., 2006) and the other is
based on E. coli expressing OspA (Gomes-Solecki et al., 2006).
Both systems are equally effective in eliciting production of pro-
tective levels of anti-OspA antibodies in inbred M. musculus and
in outbred P. leucopus mice that receive the vaccine orally either
via oral gavage or via ad libitum feeding. Furthermore, both
vaccines are equally effective in decreasing B. burgdorferi from
infected ticks that fed on vaccinated mice (Gomes-Solecki et al.,
2006; Scheckelhoff et al., 2006; Bhattacharya et al., 2011; Meirelles
Richer et al., 2011). While VV-based vaccines require a desir-
able low number of doses to induce protective immune responses
in the host, they are also potentially infectious to people who
are immunocompromised or suffer from eczema (Reed et al.,
2012). The bacteria-based delivery system, on the other hand,
requires that a higher number of vaccine doses be deployed to
induce protective immune responses in the host, which burdens
any distribution plan, but it is also considered a safer approach.
In an alternative approach, a doxycycline rodent bait formula-
tion prevented tick transmission of B. burgdorferi to vertebrate
hosts as well as cured established infections in mice (Dolan et al.,
2008; Zeidner et al., 2008). A decrease in tick infection with
B. burgdorferi, as well as the decrease of vertebrate host infection
is expected to result in an overall decrease in human risk of Lyme
disease.
A 1-year field study testing the effect of a reservoir targeted
vaccine in Lyme disease risk was done in Connecticut in 1998 and
it was repeated in 2002 (Tsao et al., 2004). Mice were trapped,
injected subcutaneously with an OspA-based suspension, and
in the following year ticks were collected in immediate sur-
rounding areas to test for infection with B. burgdorferi. The year
after deployment of the RTV, nymphal infection prevalence was
reduced by ∼24%. A comprehensive 5-year field study of an oral
RTV against B. burgdorferi was reported recently (Richer et al.,
2014). The second study differed from the first in vaccine for-
mulation (oral bait delivery of vaccine comprised of bacteria
previously induced to produce OspA) and duration of vaccine
treatment (treatment up to 5 years). The field study results
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FIGURE 1 | Proposed strategy to break the enzootic cycle of the Lyme
disease spirochete. (A) The triad which comprises the enzootic cycle: the
tick vector (Ixodes sp.), the major reservoir host (white-footed mouse) and
Borrelia burgdorferi. (B) Hypothesis: immunizing wild white-footed mice with
oral reservoir targeted vaccine (RTV) could break the enzootic cycle of
B. burgdorferi.
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yearly to trapped wild white-footed mice resulted in reduced
infection rates of nymphal ticks the year after RTV deployment
(23%) and that 5 years of consecutive treatment caused a sub-
stantial disruption of the enzootic cycle of B. burgdorferi with
reductions in nymphal infection prevalence as high as 76%.
The VV based RTV was not tested in field studies. These data
offer empirical support to an analysis using a dynamic model of
B. burgdorferi transmission which predicted that mouse-reservoir
vaccination was expected to reduce infection prevalence amongst
ticks by 56% (Tsao et al., 2012).
Such decreases in the prevalence of infected I. scapularis vec-
tors could significantly reduce the risk to humans and other
accidental mammalian hosts (such as dogs) of acquiring Lyme
disease. Implementation of a reservoir targeted vaccine (RTV)
as part of integrated pest management interventions to block
transmission of B. burgdorferi should consider deployment both
in sylvatic as well as in suburban areas and broad distribution
of such vaccines should take into account issues of toxicity to
humans.
STRENGTHS, LIMITATIONS, AND FRAMEWORK FOR
APPLICATION
A major strength of a reservoir targeted vaccine approach is
to bypass immunizing humans instantly avoiding potential vac-
cine failures and side effects (Monath, 2013); additionally, for
Lyme disease, the RTV objective is to remove only the pathogen
(B. burgdorferi) from the ecosystem while leaving all other liv-
ing components of the enzootic cycle undisturbed (Richer et al.,
2014). RTVs control infections acquired from wild animals,
which leads to collaborations between animal and human health
industries that, in turn, should lead to implementation of more
robust public health measures. Furthermore, accelerated regu-
latory pathways should lead to faster licensing of new vaccines
(Monath, 2013).
One of the limitations of the anti-Borrelia RTVs described is
that both are based in a single immunogen, OspA, which neu-
tralizes the spirochete in the tick midgut (Fikrig et al., 1992a,b;
de Silva et al., 1996). A vaccine based on OspA supplemented
with assorted OspC types (Earnhart andMarconi, 2007; Earnhart
et al., 2007) may be more efficacious given that targeting both the
vector (OspA) and the host (OspC) would contribute to protec-
tion. Only one of the reservoir species that contribute B. burgdor-
feri to the enzootic cycle—mice—was targeted for treatment
(Tsao et al., 2004; Gomes-Solecki et al., 2006; Scheckelhoff et al.,
2006; Dolan et al., 2008; Zeidner et al., 2008; Bhattacharya et al.,
2011; Meirelles Richer et al., 2011; Richer et al., 2014). Other
small vertebrates such as chipmunks, squirrels, and shrews also
transmit B. burgdorferi effectively to the tick (LoGiudice et al.,
2003; Dykhuizen et al., 2008; Mannelli et al., 2012) and should
be included in integrated pest management interventions. RTVs
are not designed to reduce tick density, which is considered to
be an important eco-epidemiological measure of Lyme disease
risk (Ogden and Tsao, 2009; Mannelli et al., 2012). A multi-
pronged integrated pest management intervention comprised of
RTV treatment to reduce pathogen burden in the ticks sup-
plemented by acaricide treatment to reduce tick density and
by vaccination of humans at risk of infection maybe the most
effective route to drastically reduce incidence of Lyme disease in
human populations.
SUMMARY
Reservoir targeted vaccines are under development for prevention
of transmission of B. burgdorferi as a means to reduce Lyme dis-
ease risk. Oral vaccines administered to mice using virus-based or
bacteria-based delivery vehicles expressing OspA reduced B. bur-
dorferi from the tick vector in the laboratory. Dynamic models of
B. burgdorferi transmission predicted that mouse-reservoir vac-
cination was expected to reduce infection prevalence amongst
ticks by 56%. OspA based RTVs tested in short-term (1-year) and
long-term (5-year) field trials lead to reductions of tick infection
prevalence ranging from 24 to 76%, respectively. Other reser-
voir targeted approaches reduced infection prevalence in the tick
vector as well as cured infection in the reservoir host. A multi-
pronged integrated pest management intervention combined
with human vaccination maybe the most effective route to dras-
tically reduce Lyme disease incidence. Lastly, eco-epidemiological
factors should be studied to understand the relationship between
the pathogen, the tick, the hosts, and its environs to be able to
assess the long-term effects of any strategies that may affect the
ecosystem.
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